| Year |
Citation |
Score |
| 2023 |
Castner SA, Zhang L, Yang CR, Hao J, Cramer JW, Wang X, Bruns RF, Marston H, Svensson KA, Williams GV. Effects of DPTQ, a novel positive allosteric modulator of the dopamine D1 receptor, on spontaneous eye blink rate and spatial working memory in the nonhuman primate. Psychopharmacology. PMID 36961560 DOI: 10.1007/s00213-022-06282-7 |
0.323 |
|
| 2020 |
Kozak R, Kiss T, Dlugolenski K, Johnson DE, Gorczyca RR, Kuszpit K, Harvey BD, Stolyar P, Sukoff Rizzo SJ, Hoffmann WE, Volfson D, Hajós M, Davoren JE, Abbott AL, Williams GV, ... Castner SA, et al. Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Frontiers in Pharmacology. 11: 1005. PMID 32733245 DOI: 10.3389/Fphar.2020.01005 |
0.407 |
|
| 2010 |
Selemon LD, Begović A, Williams GV, Castner SA. Reversal of neuronal and cognitive consequences of amphetamine sensitization following chronic treatment with a D1 antagonist. Pharmacology, Biochemistry, and Behavior. 96: 325-32. PMID 20600252 DOI: 10.1016/j.pbb.2010.06.002 |
0.388 |
|
| 2010 |
Roberts BM, Seymour PA, Schmidt CJ, Williams GV, Castner SA. Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists. Psychopharmacology. 210: 407-18. PMID 20401749 DOI: 10.1007/s00213-010-1840-9 |
0.443 |
|
| 2010 |
Roberts BM, Holden DE, Shaffer CL, Seymour PA, Menniti FS, Schmidt CJ, Williams GV, Castner SA. Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction. Behavioural Brain Research. 212: 41-8. PMID 20347881 DOI: 10.1016/j.bbr.2010.03.039 |
0.329 |
|
| 2010 |
Castner SA, Arriza JL, Roberts JC, Mrzljak L, Christian EP, Williams GV. Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023. Biological Psychiatry. 67: 998-1001. PMID 20189164 DOI: 10.1016/j.biopsych.2010.01.001 |
0.313 |
|
| 2010 |
Roberts BM, Shaffer CL, Seymour PA, Schmidt CJ, Williams GV, Castner SA. Glycine transporter inhibition reverses ketamine-induced working memory deficits. Neuroreport. 21: 390-4. PMID 20186106 DOI: 10.1097/WNR.0b013e3283381a4e |
0.35 |
|
| 2008 |
Williams GV, Castner SA. Dissecting the biology of prefrontal cortical dysfunction in schizophrenia: deficiency in mnemonic processing. Biological Psychiatry. 64: 1024-5. PMID 19038603 DOI: 10.1016/j.biopsych.2008.10.016 |
0.305 |
|
| 2007 |
Castner SA, Williams GV. From vice to virtue: insights from sensitization in the nonhuman primate. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 1572-92. PMID 17904719 DOI: 10.1016/j.pnpbp.2007.08.026 |
0.497 |
|
| 2007 |
Castner SA, Williams GV. Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain and Cognition. 63: 94-122. PMID 17204357 DOI: 10.1016/j.bandc.2006.11.002 |
0.328 |
|
| 2007 |
Selemon LD, Begović A, Goldman-Rakic PS, Castner SA. Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 919-31. PMID 16936713 DOI: 10.1038/sj.npp.1301179 |
0.559 |
|
| 2006 |
Williams GV, Castner SA. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience. 139: 263-76. PMID 16310964 DOI: 10.1016/j.neuroscience.2005.09.028 |
0.448 |
|
| 2005 |
Castner SA, Vosler PS, Goldman-Rakic PS. Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex. Biological Psychiatry. 57: 743-51. PMID 15820231 DOI: 10.1016/j.biopsych.2004.12.019 |
0.616 |
|
| 2004 |
Castner SA, Goldman-Rakic PS, Williams GV. Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology. 174: 111-25. PMID 15205882 DOI: 10.1007/s00213-003-1710-9 |
0.555 |
|
| 2004 |
Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology. 174: 3-16. PMID 15118803 DOI: 10.1007/s00213-004-1793-y |
0.603 |
|
| 2004 |
Castner SA, Goldman-Rakic PS. Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 1446-50. PMID 14960617 DOI: 10.1523/JNEUROSCI.3987-03.2004 |
0.558 |
|
| 2003 |
Castner SA, Goldman-Rakic PS. Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates. Biological Psychiatry. 54: 105-10. PMID 12873799 DOI: 10.1016/S0006-3223(03)00292-0 |
0.574 |
|
| 2001 |
Lidow MS, Song ZM, Castner SA, Allen PB, Greengard P, Goldman-Rakic PS. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biological Psychiatry. 49: 1-12. PMID 11163774 DOI: 10.1016/S0006-3223(00)01058-1 |
0.502 |
|
| 2000 |
Aleman A, F de Haan EH, Castner SA, Williams GV, Goldman-Rakic PS. Antipsychotics and working memory in schizophrenia. Science (New York, N.Y.). 289: 56b-8b. PMID 17832962 DOI: 10.1126/Science.289.5476.56B |
0.517 |
|
| 2000 |
Castner SA, Williams GV, Goldman-Rakic PS. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science (New York, N.Y.). 287: 2020-2. PMID 10720329 DOI: 10.1126/science.287.5460.2020 |
0.579 |
|
| 2000 |
Castner SA, al-Tikriti MS, Baldwin RM, Seibyl JP, Innis RB, Goldman-Rakic PS. Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 4-13. PMID 10633485 DOI: 10.1016/S0893-133X(99)00080-9 |
0.558 |
|
| 2000 |
Goldman-Rakic P, Castner S, Williams G. 204. Clinical implications of the inverted U-shaped curve relating D1 stimulation and behavior Biological Psychiatry. 47: S62. DOI: 10.1016/S0006-3223(00)00296-1 |
0.486 |
|
| 1999 |
Castner SA, Goldman-Rakic PS. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 10-28. PMID 9885781 DOI: 10.1016/S0893-133X(98)00050-5 |
0.561 |
|
| 1996 |
Castner SA, Becker JB. Sex differences in the effect of amphetamine on immediate early gene expression in the rat dorsal striatum. Brain Research. 712: 245-57. PMID 8814899 DOI: 10.1016/0006-8993(95)01429-2 |
0.519 |
|
| 1996 |
Castner S, Goldman-Rakic P. Amphetamine psychosis in male and female rhesus monkeys Biological Psychiatry. 39: 590-591. DOI: 10.1016/0006-3223(96)84255-7 |
0.446 |
|
| 1993 |
Castner SA, Xiao L, Becker JB. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Research. 610: 127-34. PMID 8518920 DOI: 10.1016/0006-8993(93)91225-H |
0.575 |
|
| Show low-probability matches. |